open access

Vol 91, No 8 (2020)
Guidelines / Expert consensus
Published online: 2020-08-31
Get Citation

Practice guidelines of the Polish Society of Gynecologists and Obstetricians — Ultrasound Section for ultrasound screening in uncomplicated pregnancy — 2020

Dariusz Borowski, Marek Pietryga, Pawel Basta, Wojciech Cnota, Bartosz Czuba, Mariusz Dubiel, Tomasz Fuchs, Hubert Huras, Rafal Iciek, Renata Jaczynska, Piotr Kaczmarek, Przemyslaw Kosinski, Sebastian Kwiatkowski, Agnieszka Nocun, Michal Pomorski, Mariola Ropcka-Lesiak, Magda Rybak-Krzyszkowska, Piotr Sieroszewski, Piotr Wegrzyn, Marcin Wiechec, Miroslaw Wielgos, Mariusz Zimmer
·
Pubmed: 32902850
·
Ginekol Pol 2020;91(8):490-501.

open access

Vol 91, No 8 (2020)
RECOMMENDATIONS
Published online: 2020-08-31

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Practice guidelines of the Polish Society of Gynecologists and Obstetricians — Ultrasound Section for ultrasound screening in uncomplicated pregnancy — 2020

Journal

Ginekologia Polska

Issue

Vol 91, No 8 (2020)

Article type

Guidelines / Expert consensus

Pages

490-501

Published online

2020-08-31

Page views

2543

Article views/downloads

1948

DOI

10.5603/GP.2020.0110

Pubmed

32902850

Bibliographic record

Ginekol Pol 2020;91(8):490-501.

Authors

Dariusz Borowski
Marek Pietryga
Pawel Basta
Wojciech Cnota
Bartosz Czuba
Mariusz Dubiel
Tomasz Fuchs
Hubert Huras
Rafal Iciek
Renata Jaczynska
Piotr Kaczmarek
Przemyslaw Kosinski
Sebastian Kwiatkowski
Agnieszka Nocun
Michal Pomorski
Mariola Ropcka-Lesiak
Magda Rybak-Krzyszkowska
Piotr Sieroszewski
Piotr Wegrzyn
Marcin Wiechec
Miroslaw Wielgos
Mariusz Zimmer

References (40)
  1. Pietryga M, Borowski D, Brązert J, et al. Polskie Towarzystwo Ginekologiczne. [Polish Gynecological Society--Ultrasound Section Guidelines on ultrasound screening in uncomplicated pregnancy--2015]. Ginekol Pol. 2015; 86(7): 551–559.
  2. Abramowicz J. Benefits and risks of ultrasound in pregnancy. Seminars in Perinatology. 2013; 37(5): 295–300.
  3. Stirnemann JJ, Chalouhi GE, Forner S, et al. First-trimester uterine scar assessment by transvaginal ultrasound. Am J Obstet Gynecol. 2011; 205(6): 551.e1–551.e6.
  4. Naji O, Wynants L, Smith A, et al. Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol. 2013; 41(6): 672–678.
  5. Jachymski T, Moczulska H, Guzowski G, et al. Conservative treatment of abnormally located intrauterine pregnancies (cervical and cesarean scar pregnancies): a multicenter analysis (Polish series). J Matern Fetal Neonatal Med. 2020; 33(6): 993–998.
  6. Timor-Tritsch IE, Fuchs KM, Monteagudo A, et al. Performing a fetal anatomy scan at the time of first-trimester screening. Obstet Gynecol. 2009; 113(2 Pt 1): 402–407.
  7. AOG. 0b013e3181954b23, indexed in Pubmed. ; 19155913.
  8. Abu-Rustum RS, Daou L, Abu-Rustum SE. Role of first-trimester sonography in the diagnosis of aneuploidy and structural fetal anomalies. J Ultrasound Med. 2010; 29(10): 1445–1452.
  9. Timor-Tritsch IE, Bashiri A, Monteagudo A, et al. Qualified and trained sonographers in the US can perform early fetal anatomy scans between 11 and 14 weeks. Am J Obstet Gynecol. 2004; 191(4): 1247–1252.
  10. Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn. 2011; 31(1): 90–102.
  11. Syngelaki A, Hammami A, Bower S, et al. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2019; 54(4): 468–476.
  12. Karim JN, Roberts NW, Salomon LJ, et al. Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance. Ultrasound Obstet Gynecol. 2017; 50(4): 429–441.
  13. Rekomendacje Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego oraz Pol-skiego Towarzystwa Genetyki Człowieka w zakresie przesiewowego badania genetycznego wykonywanego na wolnym płodowym DNA. Ginekol Pol. 2015; 86: 966–969.
  14. Bardi F, et al. Is there still a role for nuchal translucency measurement in the changing pa-radigm of first trimester screening? Prenatal Diagnosis. ; 2019: 1–9.
  15. Stirnemann JJ, Chalouhi GE, Forner S, et al. First-trimester uterine scar assessment by transvaginal ultrasound. Am J Obstet Gynecol. 2011; 205(6): 551.e1–551.e6.
  16. Naji O, Wynants L, Smith A, et al. Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol. 2013; 41(6): 672–678.
  17. Stirnemann JJ, Mousty E, Chalouhi G, et al. Screening for placenta accreta at 11-14 weeks of gestation. Am J Obstet Gynecol. 2011; 205(6): 547.e1–547.e6.
  18. Nicolaides K. Screening for fetal aneuploidies at 11 to 13 weeks. Prenatal Diagnosis. 2011; 31(1): 7–15.
  19. Chaoui R, Benoit B, Mitkowska-Wozniak H, et al. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol. 2009; 34(3): 249–252.
  20. Lachmann R, Chaoui R, Moratalla J, et al. Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn. 2011; 31(1): 103–106.
  21. Ushakov F, Sacco A, Andreeva E, et al. Crash sign: new first-trimester sonographic marker of spina bifida. Ultrasound Obstet Gynecol. 2019; 54(6): 740–745.
  22. Salomon LJ, Alfirevic Z, Bilardo CM, et al. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2013; 41(1): 102–113.
  23. Kagan KO, Cicero S, Staboulidou I, et al. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009; 33(3): 259–264.
  24. Maiz N, Wright D, Ferreira AF, et al. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation. Fetal Diagn Ther. 2012; 31(4): 221–229.
  25. Maiz N, Valencia C, Kagan KO, et al. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009; 33(5): 512–517.
  26. Kagan KO, Wright D, Valencia C, et al. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod. 2008; 23(9): 1968–1975.
  27. Salomon LJ, Sotiriadis A, Wulff CB, et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019; 54(4): 442–451.
  28. Kagan KO, Staboulidou I, Syngelaki A, et al. The 11-13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis. Ultrasound Obstet Gynecol. 2010; 36(1): 10–14.
  29. Sotiriadis A, Hernandez-Andrade E, da Silva Costa F, et al. ISUOG CSC Pre-eclampsia Task Force. ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol. 2019; 53(1): 7–22.
  30. Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145 Suppl 1: 1–33.
  31. Tan MY, Wright D, Syngelaki A, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018; 51(6): 743–750.
  32. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017; 377(7): 613–622.
  33. Prejbisz A, Dobrowolski P, Kosiński P, et al. Management of hypertension in pregnancy: prevention, diagnosis, treatment and long‑term prognosis. Kardiol Pol. 2019; 77(7-8): 757–806.
  34. Carvalho JS, Allan LD, Chaoui R, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol. 2013; 41(3): 348–359.
  35. Salomon LJ, Alfirevic Z, Bilardo CM, et al. ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011; 37(1): 116–126.
  36. ACR–ACOG–AIUM practice guideline for the performance of obstetrical ultrasound. Brown BS. The prenatal ultrasonographic diagnosis of osteogenesis imperfecta lethalis. J Can Assoc Radiol. 1984, 35, 63–66. http://www. acr.org/guidelines..
  37. Divon M, Haglund B, Nisell H, et al. Fetal and neonatal mortality in the postterm pregnancy: The impact of gestational age and fetal growth restriction. American Journal of Obstetrics and Gynecology. 1998; 178(4): 726–731.
  38. Lindqvist PG, Pettersson K, Morén A, et al. Routine Ultrasound Examination at 41 Weeks of Gestation and Risk for Postterm Severe Adverse Fetal Outcome. Obstetrical & Gynecological Survey. 2014; 69(12): 715–717.
  39. Lindqvist PG, Pettersson K, Morén A, et al. Routine ultrasound examination at 41 weeks of gestation and risk of post-term severe adverse fetal outcome: a retrospective evaluation of two units, within the same hospital, with different guidelines. BJOG: An International Journal of Obstetrics & Gynaecology. 2014; 121(9): 1108–1116.
  40. Rozporządzenie Ministra Zdrowia z dnia 16 sierpnia 2018 r.w sprawie standardu organi-zacyjnego opieki okołoporodowej, Dziennik Ustaw Rzeczypospolitej Polskiej, Warszawa, dnia 11 września 2018 r. Poz. ; 1756.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl